Cancer Communications
indexed by SCI
BMC


ORIGINAL ARTICLE
Optimized therapeutic strategy for patients with refractory or relapsed acute myeloid leukemia: long-term clinical outcomes and health-related quality of life assessment
Chen-hua Yan, Yu Wang, Yu-qian Sun, Yi-fei Cheng, Xiao-dong Mo, Feng-rong Wang, Yu-hong Chen, Yuan-yuan Zhang, Ting-ting Han, Huan Chen, Lan-ping Xu, Xiao-hui Zhang, Kai-yan Liu, Xiao-jun Huang
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/23/2022   doi:10.1002/cac2.12376
ORIGINAL ARTICLE
Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract
Huanwen Wu, Zicheng Yu, Yueping Liu, Lei Guo, Lianghong Teng, Lingchuan Guo, Li Liang, Jing Wang, Jie Gao, Ruiyu Li, Ling Yang, Xiu Nie, Dan Su, Zhiyong Liang
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/20/2022   doi:10.1002/cac2.12372
REVIEW
Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities
Tongxin Ge, Xiang Gu, Renbing Jia, Shengfang Ge, Peiwei Chai, Ai Zhuang, Xianqun Fan
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/20/2022   doi:10.1002/cac2.12374
REVIEW
The diagnosis, classification, and treatment of sarcoma in this era of artificial intelligence and immunotherapy
Amandine Crombé, Mathtieu Roulleau-Dugage, Antoine Italiano
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/19/2022   doi:10.1002/cac2.12373
LETTER TO THE EDITOR
Social-epigenetic mediators for racial disparities in pulmonary impairment among childhood cancer survivors
Nan Song, Qian Dong, Cheng Chen, Qian Li, Heather Mulder, Emily Plyler, John Easton, Emily Walker, Scott Olson, Geoffrey Neale, Kevin R. Krull, Deo Kumar Srivastava, Kirsten K. Ness, Jinghui Zhang, Melissa M. Hudson, Leslie L. Robison, I-Chan Huang, Zhaoming Wang
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/18/2022   doi:10.1002/cac2.12371
LETTER TO THE EDITOR
Malignant transformation by oncogenic K-ras requires IDH2-mediated reductive carboxylation to promote glutamine utilization
Rui Liu, Panpan Liu, Huichang Bi, Jianhua Ling, Huiqin Zhang, Mingquan Zhang, Yumin Hu, Paul J Chiao, Peng Huang, Jinyun Liu
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/17/2022   doi:10.1002/cac2.12369
LETTER TO THE EDITOR
Cell models with inducible oncogenic translocations allow to evaluate the potential of drugs to favor secondary translocations
Anna Shmakova, Nikolai Lomov, Vladimir Viushkov, Tatyana Tsfasman, Yana Kozhevnikova, Darina Sokolova, Vadim Pokrovsky, Marina Syrkina, Diego Germini, Mikhail Rubtsov, Yegor Vassetzky
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/17/2022   doi:10.1002/cac2.12370
ORIGINAL ARTICLE
SDCBP-AS1 destabilizes β-catenin by regulating ubiquitination and SUMOylation of hnRNP K to suppress gastric tumorigenicity and metastasis
Jing Han, Menglin Nie, Cong Chen, Xiaojing Cheng, Ting Guo, Longtao Huangfu, Xiaomei Li, Hong Du, Xiaofang Xing, Jiafu Ji
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/9/2022   doi:10.1002/cac2.12367
REVIEW
Current updates of CRISPR/Cas9-mediated genome editing and targeting within tumor cells: an innovative strategy of cancer management
Khaled S. Allemailem, Mohammed A Alsahli, Ahmad Almatroudi, Faris Alrumaihi, Fahd Khaleefah Alkhaleefah, Arshad Husain Rahmani, Amjad Ali Khan
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/9/2022   doi:10.1002/cac2.12366
ORIGINAL ARTICLE
N-acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4-acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA
Xiao Zheng, Qi Wang, You Zhou, Dachuan Zhang, Yiting Geng, Wenwei Hu, Changping Wu, Yufang Shi, Jingting Jiang
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/8/2022   doi:10.1002/cac2.12363

<<    Page 1 of 53  >>    




CJC Wechat 微信公众号


 

Editorial Manager


CC adopts ScholarOne Manuscripts to manage its submissions from Nov.1, 2019

 Submission Guidelines  

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CC is now published by Wiley

© Cancer Communications

651 Dongfeng Road East, Guangzhou 510060, P. R. China